Arena Reports Second Quarter Financial Results with Strong Liquidity Position, and Maintained Pipeline Progress Over the Quarter

Author's Avatar
Aug 06, 2020
Article's Main Image

- Phase 2b ADVISE trial evaluating etrasimod in atopic dermatitis (AD) enrollment complete, topline data expected Q4 2020

- Progressing first- or best-in-class drug candidates with liquidity position of ~$1.3bn as of June 30, 2020

PR Newswire